1. Introduction {#sec1}
===============

GABA~A~ Receptors (GABA~A~Rs) are ligand-gated chloride permeable ion channels which mediate both phasic (synaptic) and tonic (extrasynaptic) inhibitory neurotransmission in the central nervous system ([@bib15; @bib24]). They assemble from five subunits, the composition of which determines the receptors functional and pharmacological properties and the specific location on the neuronal membrane ([@bib24; @bib15]). GABA~A~Rs containing the γ2 subunit mediate synaptic transmission (in contrast to extrasynaptic receptors located away from the synapse) and are a target for benzodiazepines ([@bib35]). The enrichment of GABA~A~Rs in subcellular compartments such as the axon initial segment (AIS) has been reported for the α2 subunit and although both α1 and α2 subunits are found at the synapse in dendrites, a minority of GABA~A~Rs in the AIS contain the α1 subunit ([@bib33; @bib5]). GABA~A~Rs undergo dynamic movement within the cellular membrane. Lateral diffusion facilitates trafficking and assures the appropriate surface localisation of the receptor ([@bib30]), while trafficking to and from the membrane through exocytotic and endocytotic processes allows constant maintenance of the inhibitory synaptic receptor pool ([@bib4; @bib16; @bib17]). Altered neuronal activity causes surface GABA~A~Rs to undergo plasticity-induced trafficking changes. These are mediated by alterations in the activity of protein phosphatases and kinases which are linked to changes in intracellular Ca^2+^ ([@bib29; @bib2; @bib40; @bib24; @bib15; @bib34]).

SE evolves rapidly and dynamically, manifesting as a prolonged and self-sustaining seizure with significant morbidity and mortality ([@bib22; @bib10; @bib43]). This distinct condition can occur in patients with previous epilepsy or may occur *de novo* as a result of acute neurological disorders ([@bib48]). As SE evolves, the patient\'s response to treatment with benzodiazepines decreases progressively which rapidly results in benzodiazepine pharmacoresistance. This may lead to refractory SE, a pathological state in which seizures are not sopped by first- or second-line anticonvulsant therapies.

To unravel the role of benzodiazepine pharmacoresistance associated with SE patients, studies have addressed whether the trafficking of GABA~A~Rs to and from the cellular membrane is altered during models of SE ([@bib31; @bib12; @bib3]). Interestingly, it has been suggested that GABA~A~Rs are subjected to subunit-specific trafficking during prolonged depolarisation. GABA~A~Rs containing the synaptic subunits β2/3 and γ2 undergo internalisation whereas those containing the extrasynaptic δ subunit remain unchanged ([@bib11]). Despite recent studies, the temporal dynamics of GABA~A~R trafficking have not been investigated using live-cell imaging. Moreover, whether endocytosis occurs preferentially in distinct compartments such as dendrites or soma remains unclear. It is not known which molecular pathways underlie this subunit-specific trafficking of GABA~A~Rs. Furthermore, it remains to be determined whether Ca^2+^ and its intracellular signalling cascades play a significant role in the modulation of GABAergic inhibition during SE.

To address the molecular mechanisms underlying altered GABA~A~R trafficking during SE, we used a live-cell imaging approach to examine the surface stability of GABA~A~Rs in hippocampal neurons. We induced prolonged epileptiform bursting activity *in vitro* by exposing neurons to artificial cerebrospinal fluid (aCSF) lacking Mg^2+^ ([@bib25; @bib41]). Using this model, we show a decrease in somatic surface GABA~A~Rs that is dependent on NMDAR activity and the Ca^2+^-dependent phosphatase, calcineurin. Furthermore, we show that epileptiform activity alters intracellular Ca^2+^ concentrations, which correlates with the decrease of GABA~A~Rs from the surface possibly contributing to pathological signalling during SE.

2. Materials and methods {#sec2}
========================

2.1. Constructs {#sec2.1}
---------------

The N-terminally tagged GABA~A~ α~2~-~SEP~ DNA was a kind gift from S. Moss (Tufts University, Cambridge, MA) and has been described previously ([@bib47]).

2.2. Cell culture and transfection {#sec2.2}
----------------------------------

All animal experiments were carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986. All efforts were made to minimise animal suffering and to reduce the number of animals used. Dissected hippocampi of P0 rat pups or E18 embryos were immediately placed in ice-cold dissection buffer (HBSS (Invitrogen)) and washed once. Using trypsin (0.25%) tissue was digested for 10 min before trituration in ∼2 ml of attachment medium. Neurons were plated onto poly-[l]{.smallcaps}-lysine (Sigma) coated coverslips (500 μg/ml). For nucleofection, hippocampal neurons were nucleofected with GABA~A~ α~2SEP~ plasmid DNA. Neurons were centrifuged and the cell pellet was resuspended in 100 μl transfection buffer (135 mM KCL, 10 mM HEPES-pH 7.3, 2 mM MgCl~2~, 5 mM EGTA, 0.2 mM CaCl~2~) and transfected using a single cuvette AMAXA system (Lonza, programme O-003 or AK-009). Neurons were left to develop at 37 °C and 95% O~2~, 5% CO~2~ in maintenance medium \[Neurobasal (Invitrogen), B27 Supplement (Invitrogen), 0.6% Glucose (Sigma), 2 mM Glutamine (Invitrogen) and Penicillin--Streptomycin\] for 14--21 DIV before imaging.

2.3. Live-cell imaging {#sec2.3}
----------------------

Live-cell imaging was performed on an upright Olympus microscope (BX51WI) coupled to an EM-CCD camera (Ixon, Andor). Cells were imaged with a water-immersion 60× objective (Olympus). Excitation was provided by an X-cite 120Q light source (Lumen Dynamics). Appropriate filters were used (in nm): Excitation: 470/40; Emission: 525/50; Dichroic: 495, long pass. The image pixel scale was calculated by dividing the camera pixel size (16 μm) by the lens magnification (60×) yielding a pixel size of 0.27 μm. Before constant perfusion with a Cole--Parmer Master-Flex pump (∼4 ml/min), aCSF (126 mM NaCl, 24 mM NaHCO~3~, 10 mM [d]{.smallcaps}-Glucose, 2.5 mM KCL, 2 mM CaCl~2~, 1 mM MgCl, 1 mM NaH~2~PO~4~, 5 mM Sodium Pyruvate) was pre-equilibrated for 20 min with 95% O~2~ and 5% CO~2~ to establish a pH of 7.4. Temperature of the waterbath was constantly measured using a digital Thermometer (Hanna Instruments) and maintained at 37 °C. Any focus drift was corrected manually. Protocols were adapted to achieve minimal bleaching conditions. Imaging of SEP-tagged GABA~A~Rs was done for 60 min at a rate of one frame every 20 s (180 frames, 48.8 ms exposure, no averaging). For imaging of intracellular Ca^2+^ using fluo4 (1 μM, Molecular Probes, Invitrogen) hippocampal neurons were incubated for 30 min at 37 °C. After washing twice, fluo4-imaging was done for 60 min (720 frames, 5 ms exposure, no averaging) at 1 frame every 5 s.

2.4. Cell-attached recording {#sec2.4}
----------------------------

Cell-attached recordings were made on transfected hippocampal neurons at 13 DIV using an Axopatch 200B amplifier (Molecular Devices) and pClamp software. Cells were visualised using an upright Olympus BX50WI microscope equipped with a 40× water-immersion objective and infrared optics. Recording electrodes were pulled from standard-walled borosilicate glass capillaries (Warner Instruments) and filled with aCSF. Gigaseal cell attached recordings were made in voltage-clamp mode at −70 mV; the cells were constantly perfused with aCSF. To block currents during recording NBQX disodium salt (20 μM, Abcam) and dAPV (D-(−)-2-Amino-5-phosphonopentanoic acid, 25 μM, TOCRIS) were added to the perfusion solution.

2.5. Low Mg^2+^ and drug treatments {#sec2.5}
-----------------------------------

To induce epileptiform bursting activity, aCSF without Mg^2+^ but 2 μM glycine (126 mM NaCl, 24 mM NaHCO~3~, 10 mM [d]{.smallcaps}-Glucose, 2.5 mM KCL, 2 mM CaCl~2~, 1 mM NaH~2~PO~4~, 5 mM sodium pyruvate, 2 μM glycine) was used ([@bib3]). We confirmed previous studies ([@bib39; @bib25; @bib9]) that low Mg^2+^ results in cellular burst spiking that is dependent upon glutamateric transmission (Sup. [Fig.2](#appsec1){ref-type="sec"}). Moreover, action potentials were associated with post-synaptic currents, indicating that the bursting was the result of network activity (Sup. [Fig. 2](#appsec1){ref-type="sec"}). The mitochondrial substrate sodium pyruvate was supplemented to reduce neuronal death ([@bib18]). Transfected hippocampal neurons were perfused with control aCSF for 3.3 min (10 frames, baseline), followed by either low Mg^2+^ treatment or continued perfusion with aCSF with Mg^2+^ (control) for 60 min. To block NMDAR activity during low Mg^2+^ treatment, the NMDAR blocker dAPV (25 μM, TOCRIS) was used continuously throughout the low Mg^2+^ treatment without preincubation. For low Mg^2+^/NMDA treatment, NMDA (30 μM, TOCRIS) was added to the low Mg^2+^ medium and applied continuously for 60 min. To block the activity of the Ca^2+^ dependent phosphatase calcineurin, cells were pre-incubated with calcineurin autoinhibitory peptide ([@bib45]) (50 μM, Calbiochem) for 25 min at 37 °C and imaged (without application of the peptide during perfusion) either during control or low Mg^2+^ treatment ([@bib29]).

2.6. Image analysis {#sec2.6}
-------------------

Intensity analysis of specific regions of interests (ROIs: background, soma, diffuse, clustered) was done in ImageJ 1.43u which allowed the export of raw data to MatlabR2008a Software. Image correction was done in ImageJ software using the plugin StackReg macro ([@bib53]) which corrects for drift in (*x*,*y*). Inverted average intensity projection was done in ImageJ by using the Z-stack application from frame 1--10 (0--3 min) and frame 30--60 (10--20 min). Analysis of SEP-imaging raw data was done using Matlab Software through a custom designed code. Background was subtracted from each frame, fluorescence intensity was normalised to the baseline (average value of *t* = 0--3.33 min) and averaged for each experimental group. The fluorescence intensity values for each specific ROI were analysed in individual loops which allowed separate analysis. Furthermore, the standard error of mean (SEM) was calculated for each time-point and the mean normalised values including error bars were plotted against time. Ca^2+^ imaging was analysed using ImageJ. Fluorescence intensity in the soma was extracted from one ROI per cell. Baseline for 60 min Ca^2+^-imaging was the average of the first 10 frames (*t* = 0--50 s), which corresponds to control conditions.

2.7. Statistical analysis {#sec2.7}
-------------------------

All experiments were performed on neurons from at least three individual preparations. The software GraphPad Prism was used for statistical tests and to generate bar charts. Data sets were tested to determine if they were normally distributed (KS normality test) before undertaking further statistical analysis. For low Mg^2+^ only and low Mg^2+^ NMDA treatments, *p* values were determined using a Student\'s *t* test (two-tailed). Repeat measures ANOVA (for normally distributed data) or Friedman test was used to analyse significance of low Mg^2+^ induced effects during Ca^2+^-imaging, low Mg^2+^/dAPV and low Mg^2+^/CAIP experiments since there were more than two experimental groups. Appropriate post-hoc tests such as Tukey\'s for normally distributed data or Dunn\'s multiple comparison for non-normally distributed data were used. Values are given as mean ± SEM. Error bars represent SEM.

3. Results {#sec3}
==========

3.1. Surface stability of somatic GABA~A~Rs in hippocampal neurons is altered during Low Mg^2+^ treatment {#sec3.1}
---------------------------------------------------------------------------------------------------------

To examine the influence of SE on GABA~A~R stability and clustering *in vitro*, we mimicked the characteristic repetitive epileptiform bursting activity of SE by removal of Mg^2+^ from the extracellular medium of cultured hippocampal rat neurons transfected with SEP-tagged GABA~A~R α~2~ subunit (α~2SEP~) ([@bib41]). Surface GABA~A~Rs were imaged via the SEP-tag on the α~2~ subunit ([@bib29]) (which allows visualisation through high fluorescence in neutral pH, Sup. [Fig.1](#appsec1){ref-type="sec"}) for 60 min. α~2SEP~ fluorescence was analysed in 3 distinct regions of interests (ROIs): soma, diffuse (extrasynaptic compartment in dendrites) and clusters. At t = 20 min, somatic fluorescence of α~2SEP~-containing GABA~A~Rs was significantly decreased (control *F*/*F*~0~: 0.997 ± 0.02, low Mg^2+^ *F*/*F*~0~: 0.85 ± 0.05; *p* = 0.02) indicating that internalisation of GABA~A~Rs at the somatic level increases during low Mg^2+^ treatment ([Fig. 1](#fig1){ref-type="fig"}C,F). This could account for a decrease in hippocampal GABAergic inhibition during epileptiform activity. However, α~2SEP~-fluorescence intensity at the soma was not found to be significantly changed at *t* = 60 min (control *F*/*F*~0~: 0.92 ± 0.03, low Mg^2+^ *F*/*F*~0~: 1.01 ± 0.04; *p* = 0.09) suggesting a biphasic regulation of surface GABA~A~Rs during low Mg^2+^ treatment ([Fig. 1](#fig1){ref-type="fig"}C,F\'). Interestingly, α~2SEP~-GABA~A~R clusters (*t* = 20 min; control *F*/*F*~0~: 1.02 ± 0.02 low Mg^2+^ *F*/*F*~0~: 0.96 ± 0.07; *p* = 0.36) and diffuse (*t* = 20 min; control *F*/*F*~0~: 1.01 ± 0.02, low Mg^2+^ *F*/*F*~0~: 0.95 ± 0.05; *p* = 0.28) fluorescence intensity in the neuronal dendrites during low Mg^2+^ treatment showed only a minor, non-significant decrease. Our data thus indicates compartmental specificity of low Mg^2+^ induced decrease of GABA~A~Rs from the surface ([Fig. 1](#fig1){ref-type="fig"}D,E), with GABA~A~Rs primarily endocytosed from the cell soma surface.

3.2. Activity of NMDA receptors induces the down-regulation of somatic GABA~A~ receptors from the surface during Low Mg^2+^ treatment {#sec3.2}
-------------------------------------------------------------------------------------------------------------------------------------

Low extracellular Mg^2+^ induces epileptiform activity which is abolished by application of the NMDAR antagonist dAPV ([@bib8; @bib7; @bib44; @bib1; @bib51; @bib13; @bib25]). Therefore, we tested whether inhibition of NMDAR activity during low Mg^2+^ treatment blocks the somatic down-regulation of GABA~A~Rs ([Fig. 2](#fig2){ref-type="fig"}). Low Mg^2+^ alone induced a significant decrease of α~2SEP~-GABA~A~R fluorescence intensity at *t* = 20 min whereas this loss was inhibited by the co-application of dAPV (*t* = 20 min; control *F*/*F*~0~: 0.97 ± 0.05, low Mg^2+^ *F*/*F*~0~: 0.65 ± 0.03 (*p* \< 0.001), low Mg^2+^/dAPV *F*/*F*~0~: 0.96 ± 0.07 (*p* \> 0.05); one-way ANOVA test, Tukey\'s multiple comparison post test), confirming that the down regulation of surface GABA~A~Rs was dependent on the activation of NMDARs ([Fig. 2](#fig2){ref-type="fig"}C,C\').

3.3. Epileptiform activity evokes intracellular Ca^2+^ changes that correspond to the temporal dynamics of somatic surface GABA~A~R decrease {#sec3.3}
--------------------------------------------------------------------------------------------------------------------------------------------

To further explore the mechanisms of NMDAR-driven decrease in surface GABA~A~Rs during low Mg^2+^ treatment, we applied the fluorescent Ca^2+^ indicator fluo4 in low Mg^2+^ treated hippocampal neurons. This allowed us to investigate intracellular Ca^2+^ transients evoked by low Mg^2+^ treatment. Hippocampal neurons perfused with control aCSF exhibit small Ca^2+^ transients reflecting spontaneous activity, whereas low Mg^2+^ perfusion significantly altered intracellular Ca^2+^ throughout the timeline of 60 min ([Fig. 3](#fig3){ref-type="fig"}B,B\'). Fluo4 imaging reported intracellular Ca^2+^ increases rapidly upon early perfusion with low Mg^2+^ (10--20 min *F*/*F*~0~: 375.8 ± 28.4; *p* \< 0.001, Friedman test and Dunn\'s multiple comparison post test) and at t = 60 min (*F*/*F*~0~: 215.2 ± 28.8; *p* \< 0.05, Friedman test and Dunn\'s multiple comparison post test) in comparison to baseline (*t* = 100--150 s; *F*/*F*~0~: 104.5 ± 4.4), ([Fig. 3](#fig3){ref-type="fig"}C). This indicates that low Mg^2+^ treatment induces an intracellular Ca^2+^ rise, which is likely to be caused by activation of NMDARs. Interestingly, intracellular Ca^2+^ concentration drops significantly during the timeline (10--20 min, *F*/*F*~0~: 375.8 ± 28.4; 50--60 min, *F*/*F*~0~: 215.2 ± 28.8; *p* \< 0.05, Friedman test and Dunn\'s multiple comparison post test) showing that intracellular Ca^2+^ concentration undergoes alteration on a similar timescale to that of somatic surface GABA~A~R decrease ([Fig. 3](#fig3){ref-type="fig"}C).

3.4. Dispersion of clustered GABA~A~ receptors is induced by NMDA receptor activation {#sec3.4}
-------------------------------------------------------------------------------------

It has been reported that the dispersal of surface GABA~A~R clusters in neuronal processes is regulated through Ca^2+^ influx via NMDARs ([@bib29]). Therefore we tested whether further increasing the activation of NMDARs by co-application of low Mg^2+^ and the agonist NMDA would trigger dispersion of surface GABA~A~R clusters in proximal dendrites. Indeed, the activation of NMDARs with low Mg^2+^ in addition to application of the agonist NMDA (low Mg^2+^/NMDA) caused a loss of α~2SEP~ GABA~A~R fluorescence intensity in dendritic clusters ([Fig. 4](#fig4){ref-type="fig"}A,B,B\') at *t* = 20 min (control *F*/*F*~0~: 1.001 ± 0.04, low Mg^2+^/NMDA *F*/*F*~0~: 0.799 ± 0.03; *p* \< 0.01) suggesting that surface stability of GABA~A~Rs corresponds with the potency of NMDAR activation ([Fig. 4](#fig4){ref-type="fig"}C,F). Interestingly, during low Mg^2+^/NMDA perfusion diffuse (control *F*/*F*~0~: 1.02 ± 0.03, low Mg^2+^/NMDA *F*/*F*~0~: 0.95 ± 0.09, *p* = 0.58) and total (data not shown) fluorescence intensity in neuronal processes remains unaltered at *t* = 20 min ([Fig. 4](#fig4){ref-type="fig"}D,F). This indicates dispersion of surface GABA~A~R upon low Mg^2+^/NMDA. Somatic GABA~A~R fluorescence intensity is significantly decreased at *t* = 10 min after low Mg^2+^/NMDA (control *F*/*F*~0~: 1.00 ± 0.02, low Mg^2+^/NMDA *F*/*F*~0~: 0.77 ± 0.059, *p* \< 0.01) treatment, however it is not significantly altered at *t* = 20 min (control *F*/*F*~0~: 0.98 ± 0.03, low Mg^2+^/NMDA *F*/*F*~0~: 0.85 ± 0.11, *p* = 0.34) ([Fig. 4](#fig4){ref-type="fig"} E). Although the decrease in somatic surface GABA~A~Rs fluorescence intensity during low Mg^2+^/NMDA also occurs rapidly after treatment and is of similar size compared to low Mg^2+^ only treatment, the biphasic recovery phase is shorter in the low Mg^2+^/NMDA treatment.

3.5. Calcineurin mediates the decrease of GABA~A~ receptors from the surface during Low Mg^2+^ induced bursting activity {#sec3.5}
------------------------------------------------------------------------------------------------------------------------

We next investigated the signalling mechanisms involved in NMDAR mediated GABA~A~R surface decrease during epileptiform bursting activity. Calcineurin is implicated in activity-dependent regulation of GABAergic inhibition and hence could play an important role in Ca^2+^ mediated signalling, we therefore analysed its role in GABA~A~R stability during low Mg^2+^ bursting ([@bib23; @bib50; @bib6; @bib29]). Cells undergoing epileptiform activity showed a decrease in somatic GABA~A~R fluorescence intensity compared to control. We found that treating cells with a calcineurin autoinhibitory peptide did not significantly affect somatic GABA~A~R intensity (control *F*/*F*~0~: 1.07 ± 0.10, control/CAIP *F*/*F*~0~: 0.95 ± 0.03; *p* \> 0.05, one-way ANOVA test and Tukey\'s multiple comparison post test) showing that calcineurin had no effect at *t* = 20 min in control conditions ([Fig. 5](#fig5){ref-type="fig"}C,C\'). However, blocking calcineurin activity, inhibited the low Mg^2+^-induced decrease of surface GABA~A~R at the soma at *t* = 20 min significantly (low Mg^2+^ *F*/*F*~0~: 0.75 ± 0.06, low Mg^2+^/CAIP *F*/*F*~0~: 1.043 ± 0.06; *p* \< 0.05, one-way ANOVA test and Tukey\'s multiple comparison post test) ([Fig. 5](#fig5){ref-type="fig"}C,C\'). These results suggest that calcineurin activation upon Ca^2+^ influx through NMDARs is directly involved in the decrease of surface GABA~A~R triggered by epileptiform bursting activity.

4. Discussion {#sec4}
=============

GABA~A~Rs are a target for a variety of drugs including benzodiazepines, which are of high clinical relevance for first-line treatment of SE. Therefore it is likely that the modulation of surface stability of GABA~A~Rs induces or supports benzodiazepine pharmacoresistance in patients with SE. To identify potential mechanisms facilitating GABA~A~R internalisation, we performed live-imaging on SEP-tagged GABA~A~Rs. The key finding of this study shows epileptiform activity induces activation of calcineurin leading to a decrease in the number of surface GABA~A~Rs in the soma. This activity-dependent alteration of inhibitory strength is mediated by activation of NMDARs and is parallelled by an increase in intracellular Ca^2+^ which in turn is likely to activate calcineurin. These data identify a signalling mechanism underlying surface GABA~A~R decrease during SE and supports studies that report NMDAR activation regulates GABAergic inhibition ([@bib29; @bib2; @bib42]).

It is known that internalisation of GABA~A~Rs containing α, γ~2~ or β~2/3~ subunits is increased during epileptiform activity *in vitro* using low Mg^2+^ or high KCl media ([@bib3; @bib11; @bib12]). Furthermore, it has been demonstrated that GABA~A~Rs are internalised in chemoconvulsant models of SE *in vivo* ([@bib31; @bib32]). Our data supports the hypothesis that GABA~A~R internalisation occurs during prolonged seizures, by demonstrating that GABA~A~Rs which contain the α~2~ subunits are decreased during low Mg^2+^ treatment. In the majority of cells this decrease in surface GABA~A~Rs was biphasic possibly indicating an adaptational switch in inhibitory strength. Interestingly, we observe that this effect occurs preferentially in the soma but less in dendrites. Compartmental internalisation of GABA~A~Rs during SE has not been reported and the mechanisms underlying this differential regulation are unknown, but there are a number of possibilities. Firstly, it remains to be investigated to what extent intracellular Ca^2+^ buffering systems such as endoplasmic reticulum or mitochondria are contributing to surface stability of GABA~A~Rs in neurons undergoing epileptiform activity. Expression of signalling proteins in specific subcellular compartments could explain this effect. Secondly, since this study makes use of experiments based on overexpression of GABA~A~Rs, this could account for increased inhibition which could suppress a decrease of GABA~A~Rs in dendrites specifically. Omitting Mg^2+^ in the extracellular medium of cultured hippocampal neurons triggers a sequence of events leading to neuronal death ([@bib18; @bib52]). To significantly reduce neuronal cell death, mitochondrial substrate sodium pyruvate was added in our experiments. Although we control for this substitution, it would be interesting to test whether mitochondrial ATP production affects GABA~A~R trafficking during prolonged seizures. Thirdly, correlating the amount of intracellular ATP to the trafficking of GABA~A~Rs could contribute to the understanding of compartmentalised trafficking of GABA~A~R during low Mg^2+^ treatment.

A comprehensive body of literature describes that low Mg^2+^ induced epileptiform activity is dependent on increased NMDAR activity ([@bib8], [@bib7]; [@bib44; @bib1; @bib51; @bib13; @bib25]), therefore we tested whether the somatic surface GABA~A~R decrease was mediated by NMDAR activity. Our experiments confirm this hypothesis by reporting that the decrease in surface GABA~A~R was blocked by application of NMDAR blocker dAPV. To our knowledge this is the first study showing a direct regulation of GABA~A~Rs by NMDAR activation during low Mg^2+^ induced epileptiform activity. However, whether the same process underlies the regulation of GABA~A~Rs during epileptiform activity induced by different approaches ([@bib11; @bib21]) remains to be determined. The observation that NMDAR activation and rises in internal calcium are common to all models of SE ([@bib36; @bib37; @bib28]) would suggest that this is a universal mechanism.

Interestingly, the direct activation of NMDARs with low Mg^2+^ and NMDA induces a potent change in surface stability of GABA~A~R clusters. The mechanisms underlying this modulation need further investigation, however dephosphorylation of GABA~A~R γ2 subunits could play a role ([@bib29]). Our data suggest that potency of NMDAR activation correlates with the extent of GABA~A~R modification, and may explain the synergistic effect of benzodiazepines and NMDAR antagonists in the treatment of SE ([@bib38; @bib27]).

Ca^2+^ influx from the extracellular environment through NMDARs can alter the stability of inhibitory neurotransmitter receptors ([@bib2; @bib29]). Bannai et al. showed that diffusion dynamics of GABA~A~Rs too are tuned by Ca^2+^ entry from the extracellular space. Indeed, here we report an increase in intracellular Ca^2+^ concentration during low Mg^2+^ treatment. Moreover, Ca^2+^ levels correlate with the temporal dynamics of the low Mg^2+^ induced effect on GABA~A~Rs. This indicates that fast Ca^2+^-signalling could indirectly be altering GABA~A~Rs surface stability. Although technically challenging, it would be of major interest to simultaneously dual record Ca^2+^ dynamics and GABA~A~Rs surface stability to better address the relationship of low Mg^2+^ induced spiking activity and GABA~A~R trafficking on a single cell level.

Surface stability of GABA~A~Rs is regulated by multiple processes which are facilitated by direct or indirect interaction with trafficking proteins ([@bib26; @bib15]). Our experiments further emphasise the relationship of indirect signalling via intracellular Ca^2+^ sensing proteins to stabilise neurotransmitter receptors. Downstream effects of Ca^2+^ sensing proteins such as calmodulin orchestrate a number of target proteins and can trigger selective effects on surface GABA~A~R stability. It is known that increased phosphorylation of GABA~A~Rs contributes to surface stability ([@bib40]). Terunuma et al. demonstrated deficits in GABA~A~R phosphorylation during SE mediated by protein kinase C ([@bib46]). Opposingly, dephosphorylation induces declustering and increases the diffusion dynamics of GABA~A~Rs ([@bib29]). Calcineurin has been shown to interact with GABA~A~Rs via the γ~2~ subunit and it modulates neuronal inhibition. Interestingly, basal and maximal activity of calcineurin is increased ([@bib19]) and subcellular distribution is altered ([@bib20]) in SE *in vivo*. However, it has been poorly investigated whether calcineurin mediates the decrease in surface GABA~A~Rs ([@bib49]). We identify calcineurin as a mediator of the decrease in surface GABA~A~R and therefore, provide a mechanism of inhibitory modulation during SE, and a potential target for therapy. Moreover, this study is the first to demonstrate a decrease in surface GABA~A~Rs by live-imaging in hippocampal neurons during SE. The identification of the underlying trafficking mechanism could account for resistance to benzodiazepines and could have additive effects on duration or frequency of seizure activity. Further research is needed to develop more effective therapeutic strategies against SE to which this study will contribute.

Appendix A. Supplementary data {#appsec1}
==============================
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![Somatic surface α~2SEP~-GABA~A~Rs decrease upon low Mg^2+^ treatment. (A) Representative average intensity projection of α~2SEP~ expression in control and low Mg^2+^ treated neurons over time (0--3 min and 10--20 min). Scale bar, 10 μm. (B) Kymograph (a line scan vertically projected over time) showing somatic (left; scale bar, 5 μm) and clustered (right; arrow heads indicate clusters; scale bar, 2 μm) α~2SEP~ fluorescence intensity over the movie in control (aCSF) conditions and in the presence of low Mg^2+^ (grey bar). Red bar on the right indicates a decrease in somatic fluorescence intensity upon low Mg^2+^ treatment. (C) Average fluorescence intensity of somatic α~2SEP~ GABA~A~R *F*/*F*~0~: control (green, *n* = 9 cells) and low Mg^2+^ (blue, *n* = 7). (D) Time course of diffuse α~2SEP~ GABA~A~R *F*/*F*~0~: control (green, *n* = 9 cells); low Mg^2+^ (purple, *n* = 7). (E) Time course of α~2SEP~ GABA~A~R clusters *F*/*F*~0~: control (green, *n* = 9 cells) and low Mg^2+^ (light blue, *n* = 7). (F) Bar graph of ROI\'s *F*/*F*~0~: soma (left), diffuse (middle) clusters (right). Significant loss of fluorescence in the soma compared to control at 20 min following low Mg^2+^ treatment (*p* = 0.02). Diffuse fluorescence is not altered at 20 min (*p* = 0.36) after low Mg^2+^ treatment. Fluorescence intensity of α~2SEP~ GABA~A~R clusters is unaltered following low Mg^2+^ treatment (*t* = 20 min; p = 0.28) compared to control. (F\') At 60 min after low Mg^2+^ treatment somatic (*p* = 0.09), diffuse (*p* = 0.85) and clustered (*p* = 0.42) fluorescence intensity are not significantly altered.\**p* \< 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr1){#fig1}

![NMDARs mediate low Mg^2+^ induced somatic α~2SEP~ GABA~A~R surface decrease. (A) Representative images of α~2SEP~ GABA~A~R fluorescence in control, low Mg^2+^ and low Mg^2+^ with dAPV (low Mg^2+^/dAPV) treated neurons as an average intensity projection over time (0--3 min and 10--20 min). Somatic α~2SEP~ GABA~A~R loss highlighted in red; scale bar, 10 μm. (B) Kymograph showing somatic (left; scale bar, 5 μm) fluorescence intensity over the movie (duration: 60 min) in control (aCSF) conditions and in the presence of low Mg^2+^ and low Mg^2+^/dAPV (grey bar). Red bar on the right indicates decrease in somatic fluorescence intensity upon low Mg^2+^ treatment and blocking of low Mg^2+^ induced effect by dAPV (B). (C) Time course of somatic α~2SEP~ GABA~A~R *F*/*F*~0~: control (green, *n* = 7 cells), low Mg^2+^ (blue, *n* = 8 cells) and low Mg^2+^/dAPV (dark blue, *n* = 6 cells). (C\') Summary of somatic *F*/*F*~0~ at 20 min after low Mg^2+^ treatment. Low Mg^2+^ induces a significant decrease (*p* \< 0.001) in somatic fluorescence intensity, which is inhibited by application of NMDAR blocker dAPV (*p* \< 0.001). \*\*\**p* \< 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr2){#fig2}

![Low Mg^2+^ treatment induces intracellular Ca^2+^ accumulation. (A) Representative average intensity projection of fluo-4 loaded neurons (coloured squares indicate individual cell bodies). (B) Raw fluorescence intensity of spontaneous Ca^2+^ transients in a neuron (bottom) and correlating kymograph (top; segmented line through somatic ROI) showing fluorescence changes over time under control (aCSF) conditions. (B\') Raw fluorescence intensity reporting low Mg^2+^ (grey bar) induced Ca^2+^ accumulation (bottom) and kymograph (top) indicating increase in fluorescence intensity. (C) Quantification of increase in intracellular Ca^2+^ (*n* = 21 cells). Between 10 and 20 min (averaged data points from min 10 to min 20) after low Mg^2+^ induction, intracellular Ca^2+^ is significantly elevated (*p* \< 0.001) compared to baseline (averaged data points from min 0 to min 3). At 50--60 min intracellular Ca^2+^ has decreased (*p* \< 0.001) compared to 10--20 min and significantly increased (*p* = 0.02) compared to the baseline. \**p* \< 0.05, \*\*\**p* \< 0.001. Scalebar, 10 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr3){#fig3}

![Clustered α~2SEP~ GABA~A~Rs decrease upon low Mg^2+^/NMDA treatment. (A) Representative average intensity projection of α~2SEP~ GABA~A~R fluorescence in control and low Mg^2+^/NMDA treated neurons over time (0--3 min and 10--20 min). Somatic α~2SEP~ GABA~A~R fluorescence highlighted in red; scale bar, 10 μm. (B) Kymograph showing somatic (left; scale bar, 5 μm) and clustered (right; scale bar, 2 μm) α~2SEP~ GABA~A~R fluorescence intensity over the movie in control (aCSF) conditions and in the presence of low Mg^2+^/NMDA (grey bar). Red bar on the right indicates decrease in somatic α~2SEP~ GABA~A~R fluorescence intensity upon low Mg^2+^/NMDA treatment. (C) Average fluorescence intensity time course of clustered α~2SEP~ GABA~A~R *F*/*F*~0~: control (green, *n* = 7 cells) and low Mg^2+^/NMDA, (light blue, *n* = 9). (D) Time course of diffuse α~2SEP~ GABA~A~R *F*/*F*~0~: control (green, *n* = 7 cells); low Mg^2+^, (purple, *n* = 9). (E) Time course of somatic α~2SEP~ GABA~A~R *F*/*F*~0~: control (green, *n* = 7 cells) and low Mg^2+^ (blue, *n* = 9). (F) Bar graph of ROI\'s *F*/*F*~0~: clusters (left), diffuse (middle) soma (right). Significant loss of fluorescence in the clusters compared to control at 20 min following after low Mg^2+^ treatment (*p* = 0.0008). Diffuse fluorescence is not altered upon low Mg^2+^ treatment at 20 min (*p* = 0.36) after low Mg^2+^ treatment. Diffuse fluorescence is unaltered following low Mg^2+^ treatment (*t* = 20 min; p = 0.58) compared to control. (F\') At 60 after low Mg^2+^ treatment clustered fluorescence intensity is still significantly reduced (*p* \< 0.001), diffuse (*p* = 0.99) and somatic (*p* = 0.63) fluorescence are not significantly altered. \**p* \< 0.05, \*\*\**p* \< 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr4){#fig4}

![Calcineurin mediates the decrease of somatic surface GABA~A~Rs during low Mg^2+^ treatment. (A) Representative images of α~2SEP~ GABA~A~R fluorescence in control, control with CAIP (control/CAIP), low Mg^2+^ and low Mg^2+^ with CAIP (low Mg^2+^/CAIP) treated neurons as an average intensity projection over time (0--3 min and 10--20 min). Scale bar, 10 μm. (B) Kymographs showing somatic (scale bar: 5 μm) fluorescence intensity over the movie (duration: 30 min) in control conditions, control/CAIP and in the presence of low Mg^2+^ and low Mg^2+^/CAIP (grey bar). Red bar on the right indicates decrease in somatic fluorescence intensity upon low Mg^2+^ treatment. (C) Average fluorescence intensity of α~2SEP~ GABA~A~R F/F0: control (light green, *n* = 6 cells); low Mg^2+^ (dark blue, *n* = 7 cells); control/CAIP (dark green, *n* = 6); low Mg^2+^/CAIP (purple, *n* = 6). (C\') Bar graph showing quantification of α~2SEP~ GABA~A~R *F*/*F*~0~ at *t* = 20 min. Somatic fluorescence intensity of low Mg^2+^ treated cells is significantly decreased compared to control at *t* = 20 min (dark blue bar, *p* \< 0.05). Treatment of low Mg^2+^ perfused cells with a calcineurin autoinhibitory peptide prevents the change in fluorescence intensity (dark green bar, *p* \< 0.05). Treatment with calcineurin autoinhibitory peptide alone does not significantly alter the fluorescence intensity of GABA~A~R α~2SEP~ (magenta bar, *p* \> 0.05). \**p* \< 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](gr5){#fig5}
